ed7d76ey

Property	Value
?:abstract	This systematic review and meta-analysis focused on randomized controlled trials (RCT) of multinutrients consisting of at least four vitamins and/or minerals as interventions for participants with psychiatric symptoms. A systematic search identified 16 RCTs that fit the inclusion criteria (n = 1719 participants) in six psychiatric categories: depression, post-disaster stress, antisocial behavior, behavioral deficits in dementia, attention-deficit/hyperactivity disorder, and autism. Grading of Recommendations, Assessment, Development and Evaluations (GRADE) was used to rate the evidence base. Significant clinical benefit was assessed using minimal clinically important differences (MIDs). Due to heterogeneity in participants, multinutrient formulas, outcome measures, and absence of complete data, only the Attention-Deficit/Hyperactivity Disorder (ADHD) category was eligible for meta-analyses. In ADHD populations, statistically and clinically significant improvements were found in global functioning, Mean Difference (MD) -3.3, p = 0.001, MID -3.26; Standardized Mean Difference (SMD) -0.49 p = 0.001 MD -0.5), clinician ratings of global improvement (MD -0.58, p = 0.001, MID -0.5) and ADHD improvement (MD -0.54, p = 0.002, MID -0.5), and clinician (but not observer) measures of ADHD inattentive symptoms (MD -1.53, p = 0.05, MID -0.5). Narrative synthesis also revealed a pattern of benefit for global measures of improvement, for example: in autism, and in participants with behavioral deficits in dementia. Post-natural disaster anxiety and the number of violent incidents in prison populations also improved. Broad-spectrum formulas (vitamins + minerals) demonstrated more robust effects than formulas with fewer ingredients. This review highlights the need for robust methodology-RCTs that report full data, including means and standard deviations for all outcomes-in order to further elucidate the effects of multinutrients for psychiatric symptoms.
is ?:annotates of	<https://research.tib.eu/covid-19/entity/ed7d76ey_hasAnnotation_C0002055> <https://research.tib.eu/covid-19/entity/ed7d76ey_hasAnnotation_C0003467> <https://research.tib.eu/covid-19/entity/ed7d76ey_hasAnnotation_C0004352> <https://research.tib.eu/covid-19/entity/ed7d76ey_hasAnnotation_C0011581> <https://research.tib.eu/covid-19/entity/ed7d76ey_hasAnnotation_C0026162> <https://research.tib.eu/covid-19/entity/ed7d76ey_hasAnnotation_C0233401> <https://research.tib.eu/covid-19/entity/ed7d76ey_hasAnnotation_C0233523> <https://research.tib.eu/covid-19/entity/ed7d76ey_hasAnnotation_C0242151> <https://research.tib.eu/covid-19/entity/ed7d76ey_hasAnnotation_C0424101> <https://research.tib.eu/covid-19/entity/ed7d76ey_hasAnnotation_C0497327> <https://research.tib.eu/covid-19/entity/ed7d76ey_hasAnnotation_C1263846> <https://research.tib.eu/covid-19/entity/ed7d76ey_hasAnnotation_C1457887>
?:creator	<https://research.tib.eu/covid-19/entity/Johnstone%2C_Jeanette_M%3B_Hughes%2C_Andrew%3B_Goldenberg%2C_Joshua_Z%3B_Romijn%2C_Amy_R%3B_Rucklidge%2C_Julia_J>
?:doi	10.3390/nu12113394
?:doi	<https://research.tib.eu/covid-19/entity/10.3390/nu12113394>
?:journal	Nutrients
?:license	cc-by
?:pmid	<https://research.tib.eu/covid-19/entity/33158241.0>
?:pmid	33158241.0
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/ed7d76ey_HAS_C0233523_COEXISTS_WITH_C0004352> <https://research.tib.eu/covid-19/entity/ed7d76ey_HAS_C0233523_COEXISTS_WITH_C0497327> <https://research.tib.eu/covid-19/entity/ed7d76ey_HAS_C0233523_COEXISTS_WITH_C1263846>
?:source	Medline
?:title	Multinutrients for the Treatment of Psychiatric Symptoms in Clinical Samples: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:year	2020-11-04

Property

Value

?:abstract

This systematic review and meta-analysis focused on randomized controlled trials (RCT) of multinutrients consisting of at least four vitamins and/or minerals as interventions for participants with psychiatric symptoms. A systematic search identified 16 RCTs that fit the inclusion criteria (n = 1719 participants) in six psychiatric categories: depression, post-disaster stress, antisocial behavior, behavioral deficits in dementia, attention-deficit/hyperactivity disorder, and autism. Grading of Recommendations, Assessment, Development and Evaluations (GRADE) was used to rate the evidence base. Significant clinical benefit was assessed using minimal clinically important differences (MIDs). Due to heterogeneity in participants, multinutrient formulas, outcome measures, and absence of complete data, only the Attention-Deficit/Hyperactivity Disorder (ADHD) category was eligible for meta-analyses. In ADHD populations, statistically and clinically significant improvements were found in global functioning, Mean Difference (MD) -3.3, p = 0.001, MID -3.26; Standardized Mean Difference (SMD) -0.49 p = 0.001 MD -0.5), clinician ratings of global improvement (MD -0.58, p = 0.001, MID -0.5) and ADHD improvement (MD -0.54, p = 0.002, MID -0.5), and clinician (but not observer) measures of ADHD inattentive symptoms (MD -1.53, p = 0.05, MID -0.5). Narrative synthesis also revealed a pattern of benefit for global measures of improvement, for example: in autism, and in participants with behavioral deficits in dementia. Post-natural disaster anxiety and the number of violent incidents in prison populations also improved. Broad-spectrum formulas (vitamins + minerals) demonstrated more robust effects than formulas with fewer ingredients. This review highlights the need for robust methodology-RCTs that report full data, including means and standard deviations for all outcomes-in order to further elucidate the effects of multinutrients for psychiatric symptoms.

is ?:annotates of